Mereo BioPharma (MREO) Return on Equity [ROE] (2023 - 2026)
Mereo BioPharma (MREO) reported Return on Equity [ROE] of -89.62% for Q2 2026, down 2.89 percentage points from -86.73% a year earlier but up 5.64 percentage points from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Mereo BioPharma posted Return on Equity [ROE] of -82.21%, down 4.63 percentage points from FY2024.
- Return on Equity [ROE] has declined for four consecutive years, though with a five-year change of +1268.62 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -77.58% in FY2024 (-19.77 pp), -57.81% in FY2023 (-10.63 pp), -47.18% in FY2022 (-81.88 pp) and 34.70% in FY2021 (+1385.53 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -1482.37% in Q3 2024 and a high of -56.00% in Q4 2023.
- Year over year, Return on Equity [ROE] gained in 1 of the last five quarters, with an average year-over-year change of +266.41 percentage points.
- Per Business Quant data, the three quarters before Q2 2026 came in at -95.26% (Q1 2026), -95.71% (Q4 2025) and -82.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.61 Bn | 1,101.20 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 635.68 Bn | 555.54 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 506.54 Bn | 479.65 Bn | 12.70 Bn | - |
| 4 | Merck | 358.37 Bn | 312.75 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.65 Bn | 256.64 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.69 Bn | 239.37 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.83 Bn | 193.23 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.33 Bn | 169.52 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn | 4.97% |
| 10 | Mereo BioPharma | 44.28 Mn | -105.63 Mn | - | -89.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -89.62% |
| Mar 31, 2026 | -95.26% |
| Dec 31, 2025 | -95.71% |
| Sep 30, 2025 | -82.51% |
| Jun 30, 2025 | -86.73% |
| Mar 31, 2025 | -77.97% |
| Sep 30, 2024 | -1,482.37% |
| Jun 30, 2024 | -60.66% |
| Mar 31, 2024 | -56.42% |
| Dec 31, 2023 | -56.00% |
API Access
Mereo BioPharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();